GSK-3/CDK5/CDK2-IN-1, an imidazole derivative, is an inhibitor of cdk5, cdk2, and GSK-3 extracted from patent WO2002010141A1, example 9a. GSK-3/CDK5/CDK2-IN-1 can be used for the research of cancer, and neurodegenerative diseases[1].
Molecular Weight:
362.42
Purity:
98.1
CAS Number:
[395074-72-3]
Formula:
C21H22N4O2
Target:
CDK,GSK-3
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted